Ignacio Perez Valero

on 30 May, 2016 9th Symposium

Efficacy of current antiretroviral therapy on CNS

Read more

Esteban MartΓ­nez

on 30 May, 2016 9th Symposium and Tags:

Characteristics of the β€œasymptomatic” HIV-infected patient with potential underlying CNS toxicity

Read more

Scott Letendre

on 30 May, 2016 9th Symposium and Tags:

Safety of current antiretroviral therapy on CNS

Read more

Andrea de Luca

on 30 May, 2016 9th Symposium and Tags:

Neurocognitive impairment and cardiovascular disease

Read more

Dora Brites

on 30 May, 2016 9th Symposium

Neuroinflammation in depression: microglia activation and dysfunction

Read more

Andrea Calcagno

on 30 May, 2016 9th Symposium and Tags:

The impact of antiretroviral therapy on central nervous system: two sides of the same coin

Read more

Natalia Gil

on 30 May, 2016 9th Symposium and Tags:

Prevalence of psychiatric comorbidities among VIH-infected patients

Read more

Isabel Ramos

on 30 May, 2016 9th Symposium and Tags:

Communication of the diagnosis of HIV infection: patients’ experiences and preferences

Read more

Josep Maria Llibre

on 30 May, 2016 9th Symposium and Tags:

Overall and CNS safety of integrase inhibitors

Read more

Sarah B. Joseph

on 30 May, 2016 9th Symposium and Tags:

Central nervous system as a reservoir for HIV: why it happens and what can be done

Read more